Central Nervous System Tumor Clinical Trial
Official title:
A Longitudinal Study of Biomarkers in Pediatric Patients With Central Nervous System Tumors
Biomarkers are small molecules that can be detected in the body fluids of patients; they
often correlate with the presence of a cancer. MicroRNAs and proteins are small molecules
which have recently been discovered in cells. They are known to be responsible for the
normal development of cells and when they are disrupted can contribute to the development of
cancer. Many previous studies have been done evaluating the expression of microRNAs and
proteins in normal tissues as well as a wide variety of cancers.
Recently, microRNAs and proteins from tumor cells have been detected circulating in the
blood of patients with cancer. This presents a novel opportunity to use microRNAs and
proteins in the blood as an early predictor of cancer as well as a marker of response to
therapy. Previous work in our labs have identified miRNAs and proteins in the blood and
cerebrospinal fluid (CSF) of pediatric patients with brain tumors.
To determine a longitudinal evaluation of the presence of microRNAs and proteins in the
blood, cerebrospinal fluid and urine of patients with central nervous system tumors from
diagnosis through the course of their treatment. Though the duration of active treatment
varies significantly based upon the diagnosis, patients will be followed for up to 24 months
after enrollment onto the study).
n/a
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04743310 -
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
|
Phase 2 | |
| Completed |
NCT02496520 -
Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults
|
Phase 1/Phase 2 | |
| Completed |
NCT00002594 -
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
|
Phase 2 | |
| Active, not recruiting |
NCT02932280 -
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
|
Phase 1/Phase 2 | |
| Completed |
NCT00078988 -
High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas
|
Phase 3 | |
| Recruiting |
NCT06104488 -
A Study of Avutometinib for People With Solid Tumor Cancers
|
Phase 1 | |
| Completed |
NCT00238264 -
Radiation Therapy in Treating Young Patients With Gliomas
|
Phase 2 | |
| Completed |
NCT00006024 -
Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
|
Phase 1 | |
| Recruiting |
NCT02012699 -
Integrated Cancer Repository for Cancer Research
|
||
| Completed |
NCT03981016 -
Medical and Surgical Management of Patients With Brain Metastases
|
N/A | |
| Recruiting |
NCT06054295 -
Somatic Mosaicism in Twins Discordant for Childhood Cancer
|
||
| Completed |
NCT00716976 -
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
|
Phase 3 | |
| Recruiting |
NCT05978557 -
Brain Slice Explants to Predict Drug Response in Brain Tumors
|
||
| Recruiting |
NCT04852354 -
Tissue Collection for Drug Screening and Bioanalysis
|
||
| Completed |
NCT00077207 -
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
|
N/A | |
| Completed |
NCT00085098 -
Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor
|
Phase 3 | |
| Active, not recruiting |
NCT03052738 -
Medical Marijuana in the Pediatric Central Nervous System Tumor Population
|
||
| Recruiting |
NCT03452774 -
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
|
||
| Terminated |
NCT04096716 -
Mapping Draining Lymph Nodes in CNS Malignancies
|
Phase 1 | |
| Recruiting |
NCT04185038 -
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
|
Phase 1 |